Page 81 - Read Online
P. 81

Farrell et al. Hepatoma Res 2020;6:18  I  http://dx.doi.org/10.20517/2394-5079.2019.019                                            Page 5 of 13


                 Used a modified diagnostic criterion  for NASH. Did not present proportion  of cirrhotic patients. Transplant  patients tend to have high adherence  and engagement with medical care,  which may account for the older and  heavier patients undergoing transplant   with NASH  Retrospective single centre study in a  region which high rates of obesity and   diabetes  Multiple centres in different regions  without a clear definition of NAFLD   Coding information
















                 N/A                   77.2%          N/A  used    N/A             58.3%      N/A


                   HCC (8.3% in 2002 vs. 10.3% in 2007  Documented diagnosis of NASH or  NASH was 2nd leading cause of OLT for  vs. 13.5% in 2012) behind HCV but the  most rapidly growing indication (4×  increase in NASH, 2× increase in HCV) Non-NASH-related HCC patients  were more likely to be men (79.2% vs.  70.6%) and were younger at time of  OLT (57.2 ± 7.6 vs. 59.3 ± 7.3) NASH-related patients had higher BMI  (33.6 ± 4.3 vs. 27.3 ± 4.9) and higher  rates of diabetes















                   obese patients with cryptogenic/ unknown aetiology of liver disease  Evidence of a fatty liver on biopsy  or imaging, with an otherwise  negative liver screen, drinking  < 21 or < 14 units of alcohol  per week respectively for at  least 5 years prior to their first  presentation with liver disease  Medical chart review  ICD codes NAFLD also defined by clinical  diagnosis (cryptogenic cirrhosis,  obese-diabetics with cryptogenic   liver disease)   Histol















                 10,061                632            18,301  (Asia 67%   of patients,   Europe 20%   and North   America   13%)  4929  1500  44


                 Retrospective cohort   study of OLT recipients   on organ registry for   HCC in US from 2002   to 2012.  Retrospective   longitudinal cohort of   consecutive HCC cases   between 2000 and   2010  The BRIDGE study.   Observational   longitudinal cohort in   42 countries between   2005 and 2012  Longitudinal cohort   study using SEER   registries to identify   patients with HCC   between 2004 and   2009  Retrospective cohort   analysis of patients   with HCC










                 USA                   UK             Multi-  regional  USA        USA        USA


                 Wong et al. [38]      Dyson et al. [34]  Park et al. [7]  Younossi et al. [8]  Mittal et al. [37]  Perumpail et al. [71]
   76   77   78   79   80   81   82   83   84   85   86